Ropinirole (0.5mg)..
Jun 17, 2023
Ropinirole (0.5mg)
ROPINPRIME is a medication primarily used to treat symptoms of Parkinson's disease. ROPINPRIME is also prescribed for the treatment of restless legs syndrome (RLS). ROPINPRIME belongs to a class of medications known as dopamine agonists, which work by stimulating dopamine receptors in the brain.
ROPINPRIME is commonly prescribed to manage the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement. ROPINPRIME helps to replenish the levels of dopamine, a neurotransmitter that is deficient in Parkinson's disease.
ROPINPRIME is available in strengths of 0.5, 1 and 2mg.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/ropinprime-0-5-133627
Recent Post
Steris Healthcare Pvt Ltd Radiates Excellence at the Dec 2025 ZEE Media Global Innovation & Leadership Summit, London!
Terbinafine 250mg & Itraconazole 100mg: The Ultimate Solution for Stubborn Fungal Infections Steris Healthcare.
Understanding Nebivolol 5mg & S-Amlodipine 2.5mg: A Powerful Combo for Heart Health
FLAVOSHIELD 500: The Complete Guide to Micronized Purified Flavonoid Fraction for Venous Health Steris Healthcare.
Unlocking Relief: How Egolix 150mg Treats Endometriosis Pain Steris Healthcare.
Isosorbide Mononitrate 60 mg in Long-Term Angina Management: Role and Best Practices Steris Healthcare.
How Ribavirin Capsules Help in Treating Chronic Viral Infections Steris Healthcare.
Mefenamic Acid With Paracetamol Suspension Effective Relief for Pain and Fever in Kids Steris Healthcare.
Levosalbutamol and Ipratropium Bromide Respirator Solution Quick Relief for Wheezing & Tight Airways Steris Healthcare.
Levosalbutamol Respiratory Solution 0.31 mg Trusted Relief for Breathing Problems Steris Healthcare.